eMedCodes logo

Treatment Set TS332080 - Treatment Set TS332080

Navigation: NDC > Supplier starting with: A > ANTIGEN LABORATORIES, INC.
Field Value
NDC Code: 49288-0702
Proprietary Name: Treatment Set TS332080
Suffix:
Non-Proprietary Name: Treatment Set TS332080
Dosage Form: INJECTION, SOLUTION
Method: INTRADERMAL; SUBCUTANEOUS
Original Marketing Date: 31-10-1986
Category Name: BLA
Application Number: BLA102223
Labeler: ANTIGEN LABORATORIES, INC.
Substance Name: ACER NEGUNDO POLLEN; CYNODON DACTYLON POLLEN; FRAXINUS AMERICANA POLLEN; POA PRATENSIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS ALBA POLLEN; SORGHUM HALEPENSE POLLEN
Active Numerator Strength: .00033; 66.67; .00033; 666.67; .00033; .00033; .00033
Active Ingredient Unit: g/mL; [BAU]/mL; g/mL; [BAU]/mL; g/mL; g/mL; g/mL
Pharm Classes: Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]
DEA Schedule: